|
|
|
|
Vol. 16, Issue 3, 1481-1490, March 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Morphogenèse et Signalisation Cellulaires, UMR144 CNRS-Institut Curie, 75248 Paris Cedex 05, France;
Queen's University Cancer Research Institute, Division of Cancer Biology and Genetics, Kingston, Ontario K7L 3N6, Canada
Submitted August 20, 2004;
Revised December 14, 2004;
Accepted December 16, 2004
Monitoring Editor: Richard Hynes
In addition to providing a regulated linkage between the membrane and the actin cytoskeleton, ezrin participates in signal transduction pathways. Here we describe that expression of the ezrin Y145F mutant delays epithelial cell spreading on fibronectin by inhibiting events leading to FAK activation. The defect in spreading was rescued by the overexpression of catalytically functional Src. We demonstrate that ezrin Y145 is phosphorylated in A431 cells stimulated with epidermal growth factor (EGF) and in v-Srctransformed cells. Moreover in cells devoid of Src, SYF-/- fibroblasts, ezrin Y145 phosphorylation could only be detected upon the introduction of an active form of Src. The phosphorylation of ezrin at Y145 required prior binding of the Src SH2 domain to ezrin. Our results further show that Src activity influences its binding to ezrin and a positive feedback mechanism for Src-mediated Y145 phosphorylation is implied. Interestingly, cells expressing ezrin Y145F did not proliferate when cultured in a 3D collagen gel. Collectively, our results demonstrate a key signaling input of Src-dependent ezrin phosphorylation in adhesion-mediated events in epithelial cells.
Address correspondence to: M. Arpin (marpin{at}curie.fr).
This article has been cited by other articles:
![]() |
R. Monni, L. Haddaoui, A. Naba, I. Gallais, M. Arpin, P. Mayeux, and F. Moreau-Gachelin Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia Blood, March 15, 2008; 111(6): 3163 - 3172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Graauw, I. Tijdens, M. B. Smeets, P. J. Hensbergen, A. M. Deelder, and B. van de Water Annexin A2 Phosphorylation Mediates Cell Scattering and Branching Morphogenesis via Cofilin Activation Mol. Cell. Biol., February 1, 2008; 28(3): 1029 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D'Angelo, S. Aresta, A. Blangy, L. Del Maestro, D. Louvard, and M. Arpin Interaction of Ezrin with the Novel Guanine Nucleotide Exchange Factor PLEKHG6 Promotes RhoG-dependent Apical Cytoskeleton Rearrangements in Epithelial Cells Mol. Biol. Cell, December 1, 2007; 18(12): 4780 - 4793. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tournaviti, S. Hannemann, S. Terjung, T. M. Kitzing, C. Stegmayer, J. Ritzerfeld, P. Walther, R. Grosse, W. Nickel, and O. T. Fackler SH4-domain-induced plasma membrane dynamization promotes bleb-associated cell motility J. Cell Sci., November 1, 2007; 120(21): 3820 - 3829. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Neumann-Giesen, I. Fernow, M. Amaddii, and R. Tikkanen Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton J. Cell Sci., February 1, 2007; 120(3): 395 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mhawech-Fauceglia, P. Dulguerov, A. Beck, M. Bonet, and A. S Allal Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy J. Clin. Pathol., February 1, 2007; 60(2): 185 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chuan, S.-T. Pang, A. Cedazo-Minguez, G. Norstedt, A. Pousette, and A. Flores-Morales Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin J. Biol. Chem., October 6, 2006; 281(40): 29938 - 29948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baumgartner, A. L. Sillman, E. M. Blackwood, J. Srivastava, N. Madson, J. W. Schilling, J. H. Wright, and D. L. Barber The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors PNAS, September 5, 2006; 103(36): 13391 - 13396. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng, L. Xu, D. Xiao, H. Zhang, X. Wu, R. Zheng, Q. Li, Y. Niu, Z. Shen, and E. Li Altered Expression of Ezrin in Esophageal Squamous Cell Carcinoma J. Histochem. Cytochem., August 1, 2006; 54(8): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, E. Davicioni, T. J. Triche, and G. Merlino The Homeoprotein Six1 Transcriptionally Activates Multiple Protumorigenic Genes but Requires Ezrin to Promote Metastasis Cancer Res., February 15, 2006; 66(4): 1982 - 1989. [Abstract] [Full Text] [PDF] |
||||